RMEI Continuing Medical Education Neuroscience

Neuroscience CE Activities

Overcoming Obstacles to Optimal Multiple Sclerosis (MS) Care in Minority Patient Populations

0.75 CE Credit(s)

Spinal Muscular Atrophy: An Interprofessional Approach

0.75 CE Credit(s)

Realizing the Promise of Interprofessional Care and Collaboration in Multiple Sclerosis

0.5 CE Credit(s)

Case-based Discussion on the Interprofessional Management of Non-Motor Symptoms in Patients with Parkinson’s Disease

CE Credit Expired

Neuroscience blog

Improving the Management of Chronic Neurodegenerative Diseases with Interprofessional Collaboration & Care

Multiple sclerosis (MS) and Parkinson’s disease (PD) are 2 highly prevalent chronic progressive neurodegenerative disorders. Over time, the accumulation and subsequent worsening of the symptoms associated with these diseases can result in disability, impaired quality of life, loss of independence, and an increased burden on caregivers.

Neuroscience
Blog

New Treatments for SMA: Should We Offer Them to Adults?

Spinal muscular atrophy (SMA) is a genetic disorder and a devastating diagnosis for children and their families that can lead to death or a lifetime of severe disability and progressively limited mobility.

Neuroscience
Blog

RMEI DECISION SUPPORT AIDS

The Evolving Role of Orexin-Based Therapy in Narcolepsy Type 1 Management

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.

Neuroscience
Decision Support Aid

Clearing the Path for the Accurate Diagnosis and Optimal Treatment of Bipolar Depression: A Clinical Convergence®

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.

Neuroscience, Psychiatry
Decision Support Aid

LATEST NEUROSCIENCE ARTICLES

Latest Neuroscience Articles

Hemiplegic Migraine April 12, 2025
A 46-year-old woman with a history of migraine with visual aura presented with a 3-hour history of headache, as well as weakness and numbness in the right arm.
John C. Feemster, Kemar E. Green
Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion April 10, 2025
In a trial involving patients with ischemic stroke due to medium-vessel occlusion, thrombectomy within 12 hours did not lead to a better functional outcome and lower mortality at 90 days than usual care.
Mayank Goyal, Johanna M. Ospel, Aravind Ganesh, Dar Dowlatshahi, David Volders, Markus A. Möhlenbruch, Mouhammad A. Jumaa, Shahid M. Nimjee, Thomas C. Booth, Brian H. Buck, James Kennedy, Jai J. Shankar, Franziska Dorn, Liqun Zhang, Christian Hametner, Sandor Nardai, Atif Zafar, William Diprose, Shabnam Vatanpour, Alexander Stebner, Salome Bosshart, Nishita Singh, Ivy Sebastian, Kazutaka Uchida, Karla J. Ryckborst, Robert Fahed, Sherry X. Hu, Dominik F. Vollherbst, Syed F. Zaidi, Vivien H. Lee, Jeremy Lynch, Jeremy L. Rempel, Rachel Teal, Anurag Trivedi, Felix J. Bode, Ayokunle Ogungbemi, Mirko Pham, Peter Orosz, Mohamad Abdalkader, Christian Taschner, Jason Tarpley, Sven Poli, Ravinder-Jeet Singh, Reade De Leacy, George Lopez, Demetrios Sahlas, Michael Chen, Paul Burns, Joanna D. Schaafsma, Richard Marigold, Arno Reich, Adewumi Amole, Thalia S. Field, Richard H. Swartz, Fabio Settecase, Gábor Lenzsér, Santiago Ortega-Gutierrez, Negar Asdaghi, Kyriakos Lobotesis, Adnan H. Siddiqui, Joerg Berrouschot, Maxim Mokin, Koji Ebersole, Hauke Schneider, Albert J. Yoo, Jennifer Mandzia, Jesse Klostranec, Changez Jadun, Tufail Patankar, Eric Sauvageau, Robert Lenthall, Lissa Peeling, Thien Huynh, Ronald Budzik, Seon-Kyu Lee, Levansri Makalanda, Michael R. Levitt, Richard J. Perry, Thant Hlaing, Babak S. Jahromi, Paul Singh, Andrew M. Demchuk, Michael D. Hill, the ESCAPE-MeVO Investigators*
Medium- and Distal-Vessel Occlusion — The Limit of Thrombectomy? April 10, 2025
Few procedures have gone through a decade of practice-changing clinical trials as impressive as thrombectomy for stroke. Beginning in 2015 with multiple trials showing a benefit with thrombectomy in early large-vessel occlusion, followed by the extended-window trials in 2018 and then the large core trials in 2023, it seemed that...
J Mocco

RMEI LIGHTNING TALKS

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.

Allergy & Immunology
2021

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.

Gastroenterology
2021